Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii

References

• Munoz-PriceLSWeinsteinRAAcinetobacter infectionNew Engl J Med2008358121271128118354105
   PubMed Web of Science ®Google Scholar
• PelegAYSeifertHPatersonDLAcinetobacter baumannii: emergence of a successful pathogenClin Microbiol Rev200821353858218625687
   PubMed Web of Science ®Google Scholar
• TiwariVTiwariMQuantitative proteomics to study carbapenem resistance in Acinetobacter baumanniiFront Microbiol2014551225309531
   PubMedGoogle Scholar
• PoirelLNordmannPCarbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClin Microbiol Infec200612982683616882287
   PubMed Web of Science ®Google Scholar
• DizbayMTunccanOGSezerBEHizelKNosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factorsScand J Infect Dis2010421074174620500117
   PubMed Web of Science ®Google Scholar
• BrownJMDormanDCRoyLPAcute renal failure due to overdosage of colistinMed J Australia19702209239245486295
   PubMedGoogle Scholar
• Koch-WeserJSidelVWFedermanEBKanarekPFinerDCEatonAEAdverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapyAnn Intern Med19707268578685448745
   PubMedGoogle Scholar
• Rodriguez GuardadoABlancoAAsensiVMultidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatmentsJ Antimicrob Chemoth2008614908913
   PubMed Web of Science ®Google Scholar
• DijkshoornLNemecASeifertHAn increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNat Rev Microbiol200751293995118007677
   PubMed Web of Science ®Google Scholar
• CarusoDMFosterKNHermansMHRickCAquacel Ag in the management of partial-thickness burns: results of a clinical trialJ Burn Care Rehabil2004251899714726745
   PubMedGoogle Scholar
• ChenSWuGZengHPreparation of high antimicrobial activity thiourea chitosan–Ag+ complexCarbohyd Polym20056013338
   Web of Science ®Google Scholar
• CaoXLChengCMaYLZhaoCSPreparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilitiesJ Mater Sci Mater Med201021102861286820652373
   PubMed Web of Science ®Google Scholar
• LiWRXieXBShiQSZengHYOu-YangYSChenYBAntibacterial activity and mechanism of silver nanoparticles on Escherichia coliAppl Microbiol Biotechnol20108541115112219669753
   PubMed Web of Science ®Google Scholar
• MirzajaniFGhassempourAAliahmadiAEsmaeiliMAAntibacterial effect of silver nanoparticles on Staphylococcus aureusRes Microbiol2011162554254921530652
   PubMed Web of Science ®Google Scholar
• KoraAJRastogiLEnhancement of antibacterial activity of capped silver nanoparticles in combination with antibiotics, on model gram-negative and gram-positive bacteriaBioinorg Chem Appl20138319355
   Google Scholar
• HuangLDaiTXuanYTegosGPHamblinMRSynergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infectionsAntimicrob Agents Chemother20115573432343821502618
   PubMed Web of Science ®Google Scholar
• JainJAroraSRajwadeJMOmrayPKhandelwalSPaknikarKMSilver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical useMol Pharm2009651388140119473014
   PubMed Web of Science ®Google Scholar
• Morones-RamirezJRWinklerJASpinaCSCollinsJJSilver enhances antibiotic activity against gram-negative bacteriaSci Transl Med20135190190ra181
   Web of Science ®Google Scholar
• SopiralaMMManginoJEGebreyesWASynergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumanniiAntimicrob Agents Chemother201054114678468320713678
   PubMed Web of Science ®Google Scholar
• OddsFCSynergy, antagonism, and what the chequerboard puts between themJ Antimicrob Chemoth200352111
   PubMed Web of Science ®Google Scholar
• MengZXNieJLingJJActivation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrestDiabetologia200952112513518949453
   PubMedGoogle Scholar
• GohSBoberekJMNakashimaNStachJGoodLConcurrent growth rate and transcript analyses reveal essential gene stringency in Escherichia coliPloS one200946e606119557168
   PubMed Web of Science ®Google Scholar
• SinghSBPhillipsJWWangJHighly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencingCurr Opin Drug Discov Devel2007102160166
   PubMedGoogle Scholar
• NakashimaNGohSGoodLTamuraTMultiple-gene silencing using antisense RNAs in Escherichia coliMethods Mol Biol201281530731922131001
   PubMedGoogle Scholar
• TimurkaynakFCanFAzapOKDemirbilekMArslanHKaramanSOIn vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care unitsInt J Antimicrob Agents200627322422816464562
   PubMed Web of Science ®Google Scholar
• YoonJUrbanCTerzianCMarianoNRahalJJIn vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumanniiAntimicrob Agents Chemother200448375375714982760
   PubMed Web of Science ®Google Scholar
• ScheetzMHQiCWarrenJRIn vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumanniiAntimicrob Agents Chemother20075151621162617307973
   PubMed Web of Science ®Google Scholar
• BeerCFoldbjergRHayashiYToxicity of silver nanoparticles – nanoparticle or silver ion?Toxicol Lett2012208328629222101214
   PubMed Web of Science ®Google Scholar
• FoldbjergRDangDAAutrupHCytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Arch Toxicol201185774375020428844
   PubMed Web of Science ®Google Scholar
• FournierPEVallenetDBarbeVComparative genomics of multidrug resistance in Acinetobacter baumanniiPLoS Genet200621e716415984
   PubMed Web of Science ®Google Scholar
• RizzelloLPompaPPNanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelinesChem Soc Rev20144351501151824292075
   PubMed Web of Science ®Google Scholar
• FloresCYMinanAGGrilloCASalvarezzaRCVericatCSchilardiPLCitrate-capped silver nanoparticles showing good bactericidal effect against both planktonic and sessile bacteria and a low cytotoxicity to osteoblastic cellsACS Appl Mater Interfaces2013583149315923534883
   PubMed Web of Science ®Google Scholar
• LambadiPRSharmaTKKumarPFacile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm controlInt J Nanomed20151021552171
   Google Scholar
• SmaniYDocobo-PérezFMcconnellMJAcinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calciumMicrob Pathogenesis2011505224232
   Google Scholar
• SarkarSLeoBFCarranzaCModulation of human macrophage responses to Mycobacterium tuberculosis by silver nanoparticles of different size and surface modificationPLoS One20151011
   Google Scholar
• PerezFHujerAMHujerKMGlobal challenge of multidrug-resistant Acinetobacter baumanniiAntimicrob Agents Ch2007511034713484
   PubMed Web of Science ®Google Scholar
• GootzTDThe forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistanceBiochem Pharmacol20067171073108416359640
   PubMed Web of Science ®Google Scholar
• LinLTanBPantapalangkoorPInhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisMBio201235429493
   Google Scholar
• RaetzCRWhitfieldCLipopolysaccharide endotoxinsAnnu Rev Biochem20027163570012045108
   PubMed Web of Science ®Google Scholar
• RayPHPurification and characterization of 3-deoxy-D-manno-octulosonate 8-phosphate synthetase from Escherichia coliJ Bacteriol198014126356446988389
   PubMedGoogle Scholar
• MeredithTCWoodardRWCharacterization of Escherichia coli D-arabinose 5-phosphate isomerase encoded by kpsF: implications for group 2 capsule biosynthesisBiochem J2006395242743216390329
   PubMedGoogle Scholar
• DonohueTJTargeted sigma factor turnover inserts negative control into a positive feedback loopMol Microbiol200973574775019682265
   PubMedGoogle Scholar
• McClureWRCechCLOn the mechanism of rifampicin inhibition of RNA synthesisJ Biol Chem19782532489498956363713
   PubMedGoogle Scholar
• HabashMBParkAJVisECSynergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilmsAntimicrob Agents Ch2014581058185830
   PubMed Web of Science ®Google Scholar
• JainJAroraSRajwadeJMSilver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical useMol Pharm2009651388140119473014
   PubMed Web of Science ®Google Scholar
• SaballsMPujolMTubauFRifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infectionsJ Antimicrob Chemoth2006583697700
   PubMed Web of Science ®Google Scholar
• MoutonJWCombination therapy as a tool to prevent emergence of bacterial resistanceInfection199927Suppl 2S24S2810885823
   PubMed Web of Science ®Google Scholar